Alpenglow has created an end-to-end 3D spatial biology solution including patented high-throughput 3D imaging
Acceptance based on results from the Phase 3 KEYNOTE-859 trial, which showed significant overall survival benefit in these patients with HER2-negative disease, regardless of PD-L1 expression
Stedycon Sted super-resolution fluorescence microscope
Patients will no longer need to travel abroad for treatment of acute cardiac diseases
Cell sorting technology supports researchers advancing new therapies
Point-of-Care solution to facilitate clinicians in quick and effective decision making
The company is one of the most profitable companies manufacturing speciality chemicals in India
The MOU will involve product collaboration from both companies with a goal of propelling PFAS destruction in groundwater globally
Omicron BA.5 continues to be the most prevalent sublineage in the United States (nearly 30% of cases) at the time of publication of the data
3D CMOS chip for connecting electroactive tissues and organoids to software
Subscribe To Our Newsletter & Stay Updated
